Cantor and LifeSci Capital are acting as joint book-running managers for the Offering. Bloom Burton is also acting as co-manager for the Offering.

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its ...

Redwood Trust (RWT) beats estimates as falling rates lift mortgage banking returns; see 2025 capital shift, leverage risks, and what to do next.

ONCE REMOVED" turns soon-to-be-razed buildings into opportunities for artists to create new, site-specific work. A Greenwood ...

Our college basketball betting picks are calling for the Red Storm's high-powered offense to blow away the Golden Eagles in Milwaukee tonight. Free St. John's vs. Marquette predictions for Wednesday, ...

Vertiv posted a Q4 ’25 book-to-bill ratio of 2.9x and doubled its FY25 backlog to $15b, signaling accelerating order momentum. Find out why VRT stock is a buy.

LSU has been poor defensively, allowing 75.3 ppg this year. That’s going to be a serious issue against a Texas team that ...

Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an ...

TORONTO, ON / ACCESS Newswire / February 2, 2026 / The Western Investment Company of Canada Limited (TSXV:WI) (“Western” or the “Company“) today announced the sale of the Company’s equity investment ...

The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be $150.0 million. Compass ...

Doug Bouquard: of $200,000. Distributable earnings for the quarter was $18,500,000 or $0.24 per common share. For the full ...

Rose to $0.25 per share, up from $0.23 in the previous quarter, fully covering the newly declared $0.23 dividend. Economic ...